首页> 外文期刊>Pharmacoepidemiology and drug safety >High agreement between parental reported inhaled corticosteroid use and pharmacy prescription data.
【24h】

High agreement between parental reported inhaled corticosteroid use and pharmacy prescription data.

机译:父母报告的吸入糖皮质激素使用与药房处方数据之间的高度一致性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

PURPOSE: This study was conducted to assess the validity of parental reported use of inhaled corticosteroids (ICS) in children. METHODS: ICS users were identified within the Prevention and Incidence of Asthma and Mite Allergy (PIAMA) birth cohort study and the PIAMA pharmacy sub-cohort which is nested within the PIAMA study. Complete medication histories were available for the first 8 years of life for children within the PIAMA pharmacy sub-cohort. Parental reported ICS use was measured by using data from questionnaires. ICS use in the pharmacy records was determined by using the Anatomical Therapeutic Chemical (ATC) codes. The proportion of overall agreement and kappa statistics with their corresponding 95% confidence intervals were calculated to quantify agreement between self-reported medication use and pharmacy prescription data. RESULTS: At all ages overall agreement was very high (>97%) and Cohen's kappa's ranged from 0.80 to 0.88 which also reflects excellent agreement between parental reported use of ICS and pharmacy prescription data. CONCLUSIONS: Our finding suggests that parental report of medication use is a reliable source of data to asses ICS use in children. The questionnaire-based medication data collected within the PIAMA study can be used to study asthma medication use in a large group of children.
机译:目的:本研究旨在评估父母报告的儿童吸入性糖皮质激素(ICS)使用的有效性。方法:在哮喘和螨虫过敏的预防和发病率(PIAMA)出生队列研究以及嵌套在PIAMA研究中的PIAMA药房子队列中确定了ICS用户。 PIAMA药房子队列中的儿童在生命的头8年可获得完整的药物史。家长报告的ICS使用情况是通过使用调查表中的数据进行衡量的。药房记录中ICS的使用是通过使用Anatomical Therapeutic Chemical(ATC)代码确定的。计算总体协议和kappa统计数据及其对应的95%置信区间的比例,以量化自我报告的药物使用和药房处方数据之间的协议。结果:在所有年龄段,总体一致性都很高(> 97%),Cohen的kappa值介于0.80至0.88之间,这也反映了父母报告的ICS使用与药房处方数据之间的极好的一致性。结论:我们的发现表明父母的药物使用报告是评估儿童ICS使用情况的可靠数据来源。 PIAMA研究中收集的基于问卷的药物治疗数据可用于研究大量儿童的哮喘药物治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号